David Williams Selected Research

iCpG-ODN

5/2013	The Toll-like receptor 9 ligand, CpG oligodeoxynucleotide, attenuates cardiac dysfunction in polymicrobial sepsis, involving activation of both phosphoinositide 3 kinase/Akt and extracellular-signal-related kinase signaling.
1/2013	CpG-ODN, the TLR9 agonist, attenuates myocardial ischemia/reperfusion injury: involving activation of PI3K/Akt signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David Williams Research Topics

Disease

37	Stroke (Strokes) 05/2024 - 04/2011
17	Ischemic Stroke 05/2024 - 04/2011
13	Neoplasms (Cancer) 01/2024 - 02/2006
10	Pain (Aches) 10/2023 - 01/2003
10	Inflammation (Inflammations) 12/2021 - 11/2008
10	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2017 - 02/2008
8	Reperfusion Injury 12/2015 - 12/2010
7	Wounds and Injuries (Trauma) 12/2023 - 07/2002
7	Hypertension (High Blood Pressure) 12/2022 - 04/2011
7	Cognitive Dysfunction 10/2021 - 03/2015
7	Myocardial Infarction 01/2020 - 01/2013
6	Infections 03/2024 - 03/2002
6	Carotid Stenosis (Carotid Artery Stenosis) 12/2022 - 01/2017
6	Pathologic Constriction (Stenosis) 12/2021 - 01/2004
6	Infarction (Infarctions) 01/2021 - 12/2010
5	Pre-Eclampsia (Preeclampsia) 01/2023 - 03/2005
5	Sepsis (Septicemia) 01/2020 - 08/2012
5	Dementia (Dementias) 01/2016 - 10/2007
5	Burns 06/2015 - 05/2011
4	Drug-Related Side Effects and Adverse Reactions 01/2024 - 10/2012
4	Atrial Fibrillation 01/2023 - 08/2011
4	Hemorrhage 12/2022 - 03/2005
4	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2020 - 01/2017
4	Dyslexia (Alexia) 01/2017 - 12/2009
4	Alzheimer Disease (Alzheimer's Disease) 01/2016 - 10/2007
4	Myocardial Ischemia (Ischemic Heart Diseases) 12/2015 - 10/2011
3	Melanoma (Melanoma, Malignant) 05/2024 - 11/2014
3	Pelvic Pain 10/2023 - 05/2012
3	Disease Progression 06/2023 - 09/2014
3	Atherosclerosis 12/2022 - 01/2019
3	Diarrhea 01/2022 - 01/2019
3	Diabetes Mellitus 01/2019 - 12/2015
3	Transient Ischemic Attack 01/2019 - 12/2015
3	Brain Ischemia (Cerebral Ischemia) 05/2016 - 12/2010
3	Hypoxia (Hypoxemia) 12/2015 - 01/2013
3	Heart Failure 12/2015 - 08/2010
3	Osteoporosis 08/2011 - 12/2004
3	Head and Neck Neoplasms (Head and Neck Cancer) 02/2009 - 03/2003
3	Xerostomia 02/2009 - 03/2003
3	Heart Diseases (Heart Disease) 04/2006 - 01/2002
2	Macular Degeneration (Age-Related Maculopathy) 07/2023 - 01/2020
2	Carotid Artery Diseases 12/2022 - 01/2020
2	Cardiomyopathies (Cardiomyopathy) 09/2022 - 01/2017
2	COVID-19 01/2022 - 01/2022
2	Atherosclerotic Plaque (Atheroma) 12/2021 - 01/2020
2	Breast Neoplasms (Breast Cancer) 08/2021 - 08/2011
2	Snake Bites (Snake Bite) 01/2021 - 01/2010
2	Obesity 05/2020 - 02/2011
2	Glioma (Gliomas) 01/2020 - 01/2019
2	Ischemia 01/2020 - 12/2015
2	Hearing Loss (Hearing Impairment) 01/2020 - 08/2002
2	Chronic Pain 01/2020 - 05/2012
2	Measles 07/2019 - 06/2009
2	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 01/2014
2	Mycoses (Diseases, Fungus) 04/2017 - 09/2003
2	Sluggish Cognitive Tempo 01/2017 - 11/2013

Drug/Important Bio-Agent (IBA)

19	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2008
10	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 01/2017 - 02/2008
9	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2022 - 01/2002
6	Toll-Like Receptors (Toll-Like Receptor)IBA 04/2014 - 10/2011
5	LigandsIBA 04/2014 - 08/2009
4	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2021 - 12/2014
4	C-Reactive ProteinIBA 04/2020 - 09/2014
3	CytokinesIBA 01/2024 - 01/2020
3	Anti-Bacterial Agents (Antibiotics)IBA 06/2023 - 01/2019
3	Nucleic AcidsIBA 01/2022 - 01/2019
3	Adalimumab (Humira)FDA Link 12/2018 - 01/2017
3	triphenyltetrazoliumIBA 06/2014 - 12/2010
3	CPG-oligonucleotideIBA 04/2014 - 01/2013
3	Vitamin D FDA LinkGeneric 01/2013 - 05/2011
3	Antidepressive Agents (Antidepressants)IBA 01/2009 - 10/2007
2	Proteins (Proteins, Gene)FDA Link 05/2024 - 01/2014
2	AntigensIBA 01/2023 - 04/2020
2	AnticoagulantsIBA 01/2023 - 03/2015
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2022 - 04/2011
2	Anthocyanins (Anthocyanin)IBA 10/2021 - 01/2021
2	InterleukinsIBA 06/2021 - 01/2017
2	Phenobarbital (Luminal)FDA Link 01/2020 - 04/2017
2	Retinaldehyde (Retinal)IBA 01/2020 - 01/2018
2	NucleotidesIBA 07/2019 - 01/2017
2	CholesterolIBA 01/2019 - 08/2018
2	LipidsIBA 08/2018 - 01/2018
2	EnzymesIBA 04/2017 - 01/2002

Therapy/Procedure

33	Therapeutics 05/2024 - 01/2002
13	Secondary Prevention 06/2021 - 01/2002
8	Thrombectomy 05/2024 - 07/2015
6	Punctures 01/2020 - 08/2012
5	Resuscitation 06/2015 - 05/2011
4	Ligation 01/2020 - 08/2012
4	Radiotherapy 08/2015 - 03/2003
4	Stents 07/2015 - 03/2005
3	Inappropriate Prescribing 01/2024 - 03/2013
3	Artificial Respiration (Mechanical Ventilation) 12/2022 - 01/2022
3	Length of Stay 12/2022 - 02/2006
3	Prostheses and Implants (Prosthesis) 06/2021 - 01/2005
3	Drug Therapy (Chemotherapy) 01/2017 - 10/2008
2	Sutures (Suture) 12/2023 - 03/2005
2	Transcatheter Aortic Valve Replacement 12/2023 - 12/2019
2	Extracorporeal Membrane Oxygenation 12/2022 - 01/2022
2	Spinal Fusion (Spondylosyndesis) 05/2020 - 11/2007